- Home
- Companies
- usa illinois
- disease patient
Refine by
Disease Patient Suppliers Near Usa Illinois
104 companies found
based inSan Diego, CALIFORNIA (USA)
We founded Hillhurst to liberate Sickle Cell Disease patients from the horrendous, recurrent, lifelong severe painful episodes and accompanying organ injury of this life limiting disease. We are a team of physicians, researchers, and drug ...
based inTel Aviv, ISRAEL
The volume of human molecular data is growing exponentially, but our analytic capabilities are growing linearly, at best. Humans alone cannot process all this data. What’s needed is a technology capable of digesting, organizing and making sense of ...
The first model to map and compare treatments, patient groups and disease mechanisms. ...
based inCambridge, UNITED KINGDOM
We’re driven by the shared purpose of breaking new ground in the discovery of new treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
CentoICU – Genetic Testing When Every Moment Counts. Up to one-third of all babies and children admitted to the ICU have a genetic disease. For many patients, early identification can make a difference in ...
based inShanghai, CHINA
RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...
based inDijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
Faecalibacterium prausnitzii (F. prau), a key bacterium to treat Crohn’s Disease Meet Faecalibacterium prausnitzii (F. prau) WHAT IS F. prau? F. prau, is a dominant member of the healthy gut microbiome. It accounts for 5% to 15% of the total ...
based inHerzlia, ISRAEL
Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of aortic arch disease including aneurysms and dissections. Endospan’s NEXUSTM Aortic Arch Stent Graft System is the first endovascular ...
based inStockholm, SWEDEN
BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of disorders that affect the Central Nervous System. These types of treatments are commonly referred to as disease modifiers. They ...
In Alzheimer’s disease soluble, toxic amyloid beta aggregates are believed to contribute to the neurodegenerative process. Lecanemab, a anti amyloid-beta protofibril antibody, selectively binds to these forms of amyloid beta and eliminates ...
based inTel Aviv, ISRAEL
Our story begins with a meeting back in 2011 between the founders, Oren Goldshtein and Dr. Eyal Orion, MD. The two of them identified the existing heart failure management as a clear unmet clinical need and tried to imagine the next stage of ...
based inHsinchu City, TAIWAN
ApexBio established in the Hsinchu Science-based Industrial Park since December 1997, the main products are used biosensor technology to create home care medical device for chronic disease patients to maintain and control their health. ApexBio ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
A majority of individuals with CD do not recover well under a GFD. Furthermore, there is still no effective means for monitoring the intestinal health of a recovering celiac other than an invasive biopsy and even that method is prone to interpretive ...
based inResearch Triangle Park, NORTH CAROLINA (USA)
Galaxy Diagnostics was launched in 2009 to commercialize a more sensitive test method for Bartonella species infection, called Bartonella ePCR. The underlying technology, developed by Galaxy cofounders, Drs. Ed Breitschwerdt and Ricardo Maggi at NC ...
A revolutionary test method to confirm active Borrelia infection. This urine-based test provides more sensitive direct detection for Borrelia burgdorferi infection at all stages of Lyme disease than standard ...
based inWayne, PENNSYLVANIA (USA)
Palvella Therapeutics was founded to serve individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. We focus on developing therapies that specifically target the root ...
based inBengaluru, INDIA
At OncoStem, we develop innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. Since 2011, our vision is to empower the ...
CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast ...
based inKvistgaard, DENMARK
Pnn Medical A/S was established in 1987 to improve the quality of life for people suffering from urinary tract obstructions. Since launch more than 90.000 units of the second-generation urological stent Memokath™ have been inserted worldwide and ...
Memokath™ 044 Urethra is a non-allergenic metallic stent used to effectively treat bulbar urethral stricture without the side-effects of major surgery, or discomfort of catheters. Memokath™ 044 Urethra is a non-allergenic metallic ...
based inRoden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone ...
based inCarlsbad, CALIFORNIA (USA)
Since 1985, B&B Medical Technologies has developed clinically proven endotracheal tube holders, tracheostomy anti- disconnect devices and nebulizers for adult and pediatric patients, and bubble CPAP valves. B&B products offer versatile applications ...
Includes everything needed for high output continuous medication nebulizer delivery. The HOPE Nebulizer Kit has proven to be a cost effective solution for delivery of continuous medication for the treatment of moderate to severe life threatening ...
based inCambridge, MASSACHUSETTS (USA)
Founded in Cambridge, Massachusetts, in 2013, Curelator develops clinical grade, personalized disease management tools for patients and clinicians. Currently, its main platform is N1-Headache, a unique patient engagement platform that delivers ...
based inFayetteville, ARIZONA (USA)
Cardiowise connects cardiac CT data with innovative new artificial intelligence (AI) algorithms that augment human decision-making within existing clinical workflows. An accurate diagnosis is the first step to preventing heart disease. CardioWise's ...
Cardiowise connects cardiac CT data with innovative new artificial intelligence (AI) algorithms that augment human decision-making within existing clinical ...
based inStillwater, MINNESOTA (USA)
Vascudyne is developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue. We are visionaries and realists in the right proportions. We are after the holy grail of bringing tissue-engineered medical products ...
Synthetic vascular grafts currently used in clinic have poor long term outcomes and low patency rates. Hyperplasia, calcification, foreign body immune response, infection, and atheroma formation are commonly encountered limiting the use of synthetic ...
